Physician

Temenuzhka Georgieva Mihaylova, MD. PHD

According to 2025 Medicare claims, Temenuzhka Mihaylova, MD. PHD (NPI: 1639458961) practices epileptologists in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1053343004; TIN: 386006309) and primary practice location at 48109-5000. Mihaylova is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Mihaylova's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 176 traditional Medicare patients, billed 583 HCPCS/CPT codes, and received $32,134 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 3,119 prescription claims across 218 beneficiaries totaling $1,273,365 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). 2023 DME data shows 17 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $80,104 to $32,134. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $421,035 to $1,273,365. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	334	1,052	$80,104
2016	271	919	$67,814
2017	248	865	$62,824
2018	250	745	$42,362
2019	254	797	$55,616
2020	199	670	$32,431
2021	213	588	$31,941
2022	193	529	$27,170
2023	197	578	$28,503
2024	176	583	$32,134

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	1,703	$421,035
2016	134	1,620	$407,865
2017	123	1,609	$568,845
2018	115	1,770	$808,813
2019	123	1,873	$825,192
2020	121	2,061	$986,450
2021	154	2,652	$1,337,855
2022	191	2,748	$1,300,501
2023	220	2,889	$1,307,610
2024	218	3,119	$1,273,365

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$1,442
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	17	$608
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	32	82	$163
95718	Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional	23	23	$104
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	53	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	36	40	$11
93042	Electrocardiogram (ecg) 1 to 3 leads with review by physician only	67	129	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	50	1,500	$228,750
Xcopri	Cenobamate	143	4,178	$178,496
Aptiom	Eslicarbazepine Acetate	58	2,520	$114,685
Fycompa	Perampanel	81	2,559	$105,215
Briviact	Brivaracetam	46	1,620	$76,214

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Temenuzhka Georgieva Mihaylova, MD. PHD?

Tedicare shows public-source Medicare data for Temenuzhka Georgieva Mihaylova, MD. PHD (NPI 1639458961), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Temenuzhka Georgieva Mihaylova, MD. PHD have ACO affiliation data?

Temenuzhka Georgieva Mihaylova, MD. PHD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Temenuzhka Georgieva Mihaylova, MD. PHD?

Temenuzhka Georgieva Mihaylova, MD. PHD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1053343004) in the available physician profile data.

Does Temenuzhka Georgieva Mihaylova, MD. PHD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.